Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial.

Murakami K, Habukawa C, Nobuta Y, Moriguchi N, Takemura T.

Biopsychosoc Med. 2012 Aug 3;6(1):16. doi: 10.1186/1751-0759-6-16.

2.

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.

J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.

PMID:
22157240
3.
4.

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG.

J Gastroenterol Hepatol. 2014 Jan;29(1):52-9. doi: 10.1111/jgh.12322.

PMID:
23829297
6.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.

Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. doi: 10.1016/j.gcb.2007.06.001. Epub 2008 Mar 4.

7.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

8.

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.

Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R.

Scand J Gastroenterol. 2011 Jun;46(6):663-72. doi: 10.3109/00365521.2011.565066. Epub 2011 Mar 28.

PMID:
21443416
9.

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.

Guglielmetti S, Mora D, Gschwender M, Popp K.

Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21.

11.

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.

Tack JF, Miner PB Jr, Fischer L, Harris MS.

Aliment Pharmacol Ther. 2011 Oct;34(8):868-77. doi: 10.1111/j.1365-2036.2011.04818.x. Epub 2011 Aug 24.

12.
13.

Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study.

Bortolotti M, Porta S.

Dig Dis Sci. 2011 Nov;56(11):3288-95. doi: 10.1007/s10620-011-1740-9. Epub 2011 May 15.

PMID:
21573941
14.

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.

Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.

J Clin Gastroenterol. 2011 Sep;45(8):679-83. doi: 10.1097/MCG.0b013e318204593e. Erratum in: J Clin Gastroenterol. 2011 Oct;45(9):838.

PMID:
21301358
15.

Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.

Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S.

Nutrition. 2014 Oct;30(10):1151-7. doi: 10.1016/j.nut.2014.02.010. Epub 2014 Feb 27.

PMID:
25194614
16.

Probiotics in the treatment of irritable bowel syndrome.

Saggioro A.

J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S104-6. Erratum in: J Clin Gastroenterol. 2005 Mar;39(3):261.

PMID:
15220671
18.

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.

Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B.

Am J Gastroenterol. 2000 May;95(5):1231-8.

PMID:
10811333
19.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

20.

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):387-94.

Supplemental Content

Support Center